close

Northwell’s Feinstein Institutes’ Dr. Kevin J. Tracey receives Cold Spring Harbor Laboratory Double Helix Medal

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

The pioneer in bioelectronic medicine was honored alongside Michael Milken at the annual ceremony in New York City

Recognized as the founding father of bioelectronic medicine, Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research, received the prestigious Double Helix Medal from Cold Spring Harbor Laboratory (CSHL) on November 10. The honor celebrates his decades-long pursuit of unraveling the mysteries of the brain's connection to the body and the role of the nervous system in controlling inflammation, research that has given rise to an entirely new field of medicine. Dr. Tracey was honored alongside philanthropist Michael Milken at the Double Helix Medals Dinner in New York City.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261116692063/en/

(Left to right) John D'Angelo, MD, president and CEO of Northwell Health; Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes for Medical Research; and Bruce Stillman, PhD, president and CEO of Cold Spring Harbor Laboratory pose at the annual Double Helix Medals Dinner on November 10, 2026. (Photo credit: Donna Alberico)

(Left to right) John D'Angelo, MD, president and CEO of Northwell Health; Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes for Medical Research; and Bruce Stillman, PhD, president and CEO of Cold Spring Harbor Laboratory pose at the annual Double Helix Medals Dinner on November 10, 2026. (Photo credit: Donna Alberico)

The Double Helix Medal, one of biology’s most distinguished honors, recognizes individuals who have made transformative breakthroughs in biomedical research, as well as those who have significantly supported and raised awareness of advances in science and medicine. Past recipients include Muhammad Ali, Michael J. Fox, Kareem Abdul-Jabbar, Katie Couric, Marlo Thomas, and Nobel laureates Jennifer Doudna, Katalin Karikó and Jim Allison, among other luminaries in science, medicine, philanthropy and public life.

“I am honored to receive the Double Helix Medal and to join a group of scientists and leaders I have long admired,” said Dr. Tracey, Karches Family Distinguished Chair in Medical Research. “This recognition also belongs to my colleagues in the lab and in industry and to the physicians and patients who took a chance on a new idea. That idea is now a treatment, and it is also a new beginning.”

Dr. Tracey is widely recognized as the pioneer of bioelectronic medicine; an innovative field of medicine that combines neuroscience, molecular medicine and bioengineering to explore how devices and other technologies can harness the body’s own systems to cure disease. His landmark 2002 discovery, published in Nature, revealed the “inflammatory reflex,” the mechanism by which the vagus nerve regulates the body’s immune response and controls inflammation. This discovery laid the scientific groundwork for the development of implantable devices that can treat chronic inflammatory diseases such as rheumatoid arthritis, Crohn’s disease and sepsis without the use of drugs.

Dr. Tracey’s research directly inspired the development of the 2025 FDA-approved SetPoint Medical device for rheumatoid arthritis, the first non-pharmacologic bioelectronic therapy for the condition, representing the ultimate realization of bench-to-bedside science. Northwell was the first health system in the nation to implant the SetPoint System.

Under Dr. Tracey’s leadership, the Feinstein Institutes has grown into the global scientific home of bioelectronic medicine, encompassing six institutes, with more than 50 research labs and 5,000 researchers and staff dedicated to producing knowledge to cure disease.

“Dr. Tracey's recognition by Cold Spring Harbor Laboratory is incredibly well-deserved and a testament to what is possible when an organization invests in research for the long term,” said John D’Angelo, MD, Northwell’s president and CEO. “His discovery of the inflammatory reflex gave rise to an entirely new field of medicine, one that is delivering life-changing results for patients right now. This is precisely why we invest in science that challenges the boundaries of what medicine can do.”

Throughout his career, Dr. Tracey has received honors recognizing his scientific contributions, including being named an “Innovator” on TIME’s 2026 TIME100 Health list. He was elected as a Fellow of the Royal Swedish Academy of Engineering Sciences – one of the highest honors for engineers and scientists in Sweden and internationally – and inducted as a Fellow of the National Academy of Inventors (NAI) Class of 2025, the highest professional distinction awarded solely to inventors, recognized specifically for his discovery of the inflammatory reflex and his founding of the field of bioelectronic medicine.

Under his leadership, the Feinstein Institutes has also earned significant institutional recognition, with the double neural bypass named to TIME’s Hall of Fame and TIME’s Best Inventions of 2024, and Northwell Health named to TIME100 Most Influential Companies 2025.

Dr. Tracey is also the author of The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes, further cementing his role as a leading voice in translating complex science for the benefit of patients and the public.

Founded in 1890, Cold Spring Harbor Laboratory is considered the birthplace of molecular biology and home to eight Nobel Prize winners. Nature has recognized CSHL as the world’s leading academic research institution for scientific impact, describing it as a “hub of breakthroughs.” The annual Double Helix Medals Dinner brought together more than 450 leaders in science, medicine, and philanthropy to celebrate visionary contributions to human health and biology.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine – an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journals Molecular Medicine and Bioelectronic Medicine. Through the Elmezzi Graduate School of Molecular Medicine, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  258.35
-8.31 (-3.12%)
AAPL  352.95
-3.32 (-0.93%)
AMD  506.40
-27.66 (-5.18%)
BAC  50.26
-0.77 (-1.50%)
GOOG  283.86
-8.66 (-2.96%)
META  626.88
-14.81 (-2.31%)
MSFT  522.54
-1.34 (-0.26%)
NVDA  157.10
-5.75 (-3.53%)
ORCL  119.58
-5.77 (-4.61%)
TSLA  378.69
-11.53 (-2.95%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at /week.